Podcasts about think tanks

Most water skiers have no idea how deep the roots of Think Tank run—or how a legendary event that started with bar tabs and college chaos now celebrates 50 years of innovation and community. Cathy Luiting, a long time former Think Tank Chair, shares behind-the-scenes stories from the early days, revealing how beer tips and wild nights transformed into one of the sport's most influential gatherings. This episode uncovers the surprising history that shaped an event that had 1500 attendees in it's hay day and helped propel show skiing into the spotlight. You'll discover:How Think Tank evolved from a humble three-event gathering in Wisconsin Rapids to a national spectacle.The legendary indoor doubles competitions at Olympia that kept everyone talking.The wildest stories from the '90s—peeing on hotel doors, lunch tray sledding, and spontaneous chaos—that fueled the event's reputation.The strategic moves across Wisconsin sites and what makes Chula Vista the perfect home for this ongoing tradition.The behind-the-scenes insights into the award show's fierce categories, close contests, and iconic winners, plus what it takes to host such a legendary celebration.Join us as we honor five decades of Think Tank and five years of The Ski Show Awards—a testament to passion, perseverance, and perfect chaos. Hit play and get inspired by the stories behind the sport's most legendary event.Today's Sponsors are.....FlymanSkis - flymanskis.comThe Board Shop - bswake.comFollow us on Social Media: Instagram - @theskishowpodcast Facebook - https://www.facebook.com/theskishowpodcast Contact The Ski Show: Email us at theskishowpodcast@gmail.com Leave us a rating and a review: https://podcasts.apple.com/us/podcast/the-ski-show-the-ultimate-show-ski-podcast/id1510243170

The DGS Think Tank with Braxton Payne & Judge Tom Frawley- h4 full 1077 Tue, 24 Feb 2026 22:37:04 +0000 xqZQGSFHiNN9n5QzqQUy75qxDHFcvann comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government The DGS Think Tank with Braxton Payne & Judge Tom Frawley- h4 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False https://player.amperwavepodcast

The “Real Show” Reminder (and why that matters) We kicked off this episode the way we often do—by being real. A quick tech hiccup, a laugh, and the reminder that this is not a polished production pretending to be perfect. It's a real show, with real people, talking about real money decisions. https://www.youtube.com/live/JDkaHi_66d8 And that imperfect start is a perfect picture of what's happening in the Infinite Banking world right now. As Infinite Banking becomes more popular, the internet makes it look clean and effortless: slick graphics, big promises, “hacks,” and fast results. But families don't need more hype. They need clarity. That's why this Nelson Nash Think Tank 2026 recap matters. It's one of the few environments where serious practitioners gather—not to sell—but to refine thinking, challenge assumptions, and protect the integrity of Nelson Nash's original message. If you're a family leader who wants to use the Infinite Banking Concept as a long-term strategy—not a short-term trend—this is for you. The “Real Show” Reminder (and why that matters)What you'll gain from this Nelson Nash Think Tank 2026 recapWhat is the Nelson Nash Think Tank (and why it's different)?Nelson Nash's first rule and the 2026 themeInternal rate of return vs volume in Infinite Banking: what families are hearing onlineWhy “maximum early cash value” can backfire in Infinite Banking policy designModified Endowment Contract (MEC) and the 7-pay test: what to knowHow to choose an Infinite Banking practitioner (and avoid bad advice)“Insurance companies are not banks”: understanding the banking processThink long range as a way of life, not a quick tacticWhere Infinite Banking is headed: young people, AI, and fintechWhat this Nelson Nash Think Tank 2026 recap means for your familyListen to the full episode (Nelson Nash Think Tank 2026 recap)Book A Strategy Call What you'll gain from this Nelson Nash Think Tank 2026 recap In this article, we're pulling back the curtain on what was shared at the Nelson Nash Think Tank 2026—a practitioner-focused environment where the emphasis was think long range, improve policy design conversations, and address the growing confusion created by clickbait marketing and “shortcut” policy claims. Here's what you'll walk away with: What the Think Tank is (and why it's not a sales event) Why “think long range” was the theme—and why families should pay attention The real issue behind “maximum early cash value” and skinny-based designs How to spot Infinite Banking misconceptions and marketing tactics What's coming with AI and fintech in life insurance—and what isn't changing Practical guidance for families who want to take control of the banking function What is the Nelson Nash Think Tank (and why it's different)? The Think Tank isn't built for the general public. It's designed to sharpen the people who teach and implement the concept. You typically attend as a practitioner, someone in the practitioner program, or as a guest of a practitioner (which can include clients or people considering becoming practitioners). It's also intentionally immersive. The days start early with breakfast, run through sessions into late afternoon, and then continue with dinners, vendor conversations, and deep discussions with fellow practitioners late into the night. You don't go to be entertained. You go to be challenged, stretched, and sharpened. And that matters right now because Infinite Banking has become more searchable, more popular, and—unfortunately—more misrepresented. When something powerful spreads quickly, stewardship matters more. Nelson Nash's first rule and the 2026 theme The theme this year was think long range, and that's not a catchy slogan. It's foundational to the Infinite Banking Concept as Nelson Nash taught it. Short-term thinking is the default posture of our culture. Social media rewards it. Marketing rewards it. Even many financial products are sold with it: “What can you get fast?” “What can you access now?” “How can you win this year?” But Infinite Banking was never meant to be a short-term move. It's meant to be a lifetime strategy. Thinking long range means you're making decisions from the perspective of: building stability, not excitement creating options, not dependence protecting your family's future, not chasing quick wins designing a system that can bless generations, not just solve this month That mindset shift is what separates families who use Infinite Banking wisely from families who get caught in the noise. Internal rate of return vs volume in Infinite Banking: what families are hearing online One of the biggest recurring themes was the temptation to judge policies primarily by internal rate of return (IRR)—especially in the early years. If you've spent any time online looking at Infinite Banking, you've likely seen people argue about illustrations, early cash value, and “best” design strategies. Many of those arguments are framed as if the only goal is maximizing the numbers as quickly as possible. But here's the problem: you can “win” an early IRR argument while losing the long-range strategy. A powerful presentation at the Think Tank used a visual approach—backed by math—to show something families need to hear clearly: focusing on early cash value often creates tradeoffs that reduce your future capacity. There are no solutions—only compromises. And a compromise isn't bad when you understand it. The danger is when someone sells a compromise like it's a guaranteed solution. The heart of the point was this: in Infinite Banking, the rate is not nearly as important as the volume of dollars you can control over your lifetime. That's how commercial banks and major financial institutions think. A small return on a massive volume becomes a large outcome. For families, that translates into a different question entirely:How much of what flows through your hands will you capture and control? That question changes everything. Why “maximum early cash value” can backfire in Infinite Banking policy design One of the most popular marketing angles today is the push for “maximum early cash value,” often achieved through skinny-based policies with high PUAs. The pitch usually sounds like this: get as much cash value as possible early so you can “put your money to work somewhere else.” Here's what often doesn't get explained. Some aggressive designs rely on structures that only allow maximum funding for a limited period (for example, seven years). After that funding window ends—often due to IRS rules tied to MEC limits—the rider or structure may drop off, and you can no longer fund in the same way. The common comeback is: “Just start another policy.” But real life isn't a spreadsheet. Starting over can reset efficiency. Health and insurability can change. Income changes. Goals change. Markets change. And a strategy that depends on you repeatedly starting new policies assumes a stability most families simply can't guarantee. The bigger concern is the mindset that this trains: a series of short sprints instead of building a lifelong system. Thinking long range means designing for durability, flexibility, and sustainability—not just speed. Modified Endowment Contract (MEC) and the 7-pay test: what to know You don't need to be a tax expert to understand why MEC rules matter, but you do need to know that they exist—because many “max fund fast” strategies bump up against them. A Modified Endowment Contract (MEC) is a policy that fails IRS funding limits (often related to the 7-pay test). When a policy becomes a MEC, the tax treatment of distributions changes, and it can reduce some of the advantages families expect when they hear “tax favored.” That's why certain policy designs are built around managing those limits—sometimes by using structures that give you a short window of maximum funding. The key takeaway is simple: if someone is promising “perfect” early cash value without explaining tradeoffs, funding limits, and long-term implications, you're not being educated. You're being marketed to. And marketing can be expensive. How to choose an Infinite Banking practitioner (and avoid bad advice) As Infinite Banking grows, a disappointing trend has emerged: clickbait content designed to stir controversy or attract attention. Some marketers now lead with “what's wrong with IBC” as a hook—even while selling it—because negativity generates clicks. That kind of infighting confuses families and erodes trust. So what should you watch for? Red flags to take seriously Be cautious if someone says or implies: “You don't have to make premium payments.” “These aren't premiums, they're deposits” (without clear explanation that it's life insurance). “You'll get cars for free if you do this long enough.” “This is the only policy design that works.” “You're borrowing at X and earning Y so you're losing money” using simplistic one-year comparisons. Another red flag: when someone makes you feel urgency—like you must act now without fully understanding what you're buying. If it feels too good to be true, your intuition is likely picking up on something real. A healthier question to ask Instead of asking, “How fast can I get cash value?” ask: “How will this policy design serve my family over decades?” “How long can I realistically fund this?” “What compromises are being made to get early access?” “How does this fit into my long-term cash flow strategy?” That's how you protect yourself—and how you start thinking like the kind of leader this strategy requires. “Insurance companies are not banks”: understanding the banking process Insurance companies have been emphasizing that they are not banks. That's true.

Die Luft- und Raumfahrt begleitet uns mit unzähligen Technologien in unserem Alltag. Dennoch hat diese Branche in puncto Image oft mit Herausforderungen zu kämpfen. In der aktuellen Folge des news aktuell Podcast sprechen wir mit Claudia Michel, Managerin für Kommunikation & Marketing bei Munich Aerospace, über die Auswirkungen der Luft- und Raumfahrt auf unser tägliches Leben und über die Gründe für das Image- und PR-Problem des Weltraums. Darüber hinaus geht es um die Rolle von Munich Aerospace bei der Förderung des aktiven Austauschs in Bayern und innerhalb der Branche. Und: Wir blicken auf Claudias persönlichen Werdegang und auf die Zusammenarbeit mit Journalistinnen und Journalisten.Gliederung: Einleitung: ab Minute 00:00 Von Agenturseite ins Forschungsnetzwerk: ab Minute 01:39 Einstieg in die Raumfahrtkommunikation: ab Minute 07:20 Was macht Munich Aerospace? ab Minute 09:00 Privatwirtschaft vs. geförderter Verein: ab Minute 12:32 Zusammenarbeit mit Journalisten: ab Minute 14:22 Warum hat Space ein PR-Problem? ab Minute 16:14 Awareness schaffen: ab Minute 17:47 Herausforderungen und Kritik begegnen: ab Minute 20:10 Wie kommuniziert ein Raumfahrtverein nach außen? ab Minute 22:39 Nachfassen erwünscht: ab Minute 28:24 New-Space-Akteure – von der staatlichen zur privaten Raumfahrt: ab Minute 31:51 Munich Space Summit: ab Minute 36:04 Gamechangerfrage: ab Minute 39:30 Schlussworte: ab Minute 43:31 Claudia Michel auf LinkedInMunich Aerospace im WebMunich Aerospace auf LinkedInMunich Space Summit im WebPodcast „startklar – Luft- und Raumfahrt in deinem Alltag“Am Host-Mikrofon: Marissa Neureiter und Beatrix TaFragen, Anregungen oder Feedback? Schreibt uns: podcast@newsaktuell.deHashtag für Social Media: #napodcastIn unserem news aktuell Podcast begrüßen wir regelmäßig Gäste aus den Bereichen PR, Kommunikation und Marketing. Mit ihnen sprechen wir über aktuelle Themen und Trends ihrer Branche sowie über ihren individuellen Werdegang. Der Podcast ist eine Produktion der dpa-Tochter news aktuell. Weitere Informationen zu news aktuell: www.newsaktuell.de. Vita Claudia MichelClaudia Michel, geb. Kirchmair, verantwortet seit April 2025 in einer eigens geschaffenen Position die Kommunikations- und Marketingmaßnahmen von Munich Aerospace, dem Bayerischen Forschungsnetzwerk für die Luft- und Raumfahrt. Zu ihren Kernaufgaben zählen die Steigerung der Bekanntheit und die Vermarktung des Forschungsnetzwerks insgesamt, aber auch seiner verschiedenen Services, Projekte und Netzwerkformate über alle relevanten Kanäle hinweg und bei allen Stakeholdern. Diese sind Studierende ebenso wie Professoren, Politiker, Unternehmen, Start-ups, Think Tanks und Vereine. Die gebürtige Österreicherin verfügt über mehr als 15 Jahre Berufserfahrung als Kommunikatorin. Nach ihren ersten beruflichen Schritten als Journalistin beim ORF (Österreichischen Rundfunk) war sie drei Jahre lang in der Pressestelle der Wirtschaftskammer Tirol tätig. Im Herbst 2011 kam sie ins Corporate Communications & PR Team der Serviceplan Group in München und war über die Jahre hinweg maßgeblich am Auf- und Ausbau der Abteilung beteiligt, als sich die Agenturgruppe zum globalen Player am Agenturmarkt entwickelte. Nach ihrer Elternzeit entschied sie sich für einen Wechsel des Arbeitgebers.

I'm the originator behind ControlAI's Direct Institutional Plan (the DIP), built to address extinction risks from superintelligence. My diagnosis is simple: most laypeople and policy makers have not heard of AGI, ASI, extinction risks, or what it takes to prevent the development of ASI. Instead, most AI Policy Organisations and Think Tanks act as if “Persuasion” was the bottleneck. This is why they care so much about respectability, the Overton Window, and other similar social considerations. Before we started the DIP, many of these experts stated that our topics were too far out of the Overton Window. They warned that politicians could not hear about binding regulation, extinction risks, and superintelligence. Some mentioned “downside risks” and recommended that we focus instead on “current issues”. They were wrong. In the UK, in little more than a year, we have briefed +150 lawmakers, and so far, 112 have supported our campaign about binding regulation, extinction risks and superintelligence. The Simple Pipeline In my experience, the way things work is through a straightforward pipeline: Attention. Getting the attention of people. At ControlAI, we do it through ads for lay people, and through cold emails for politicians. Information. Telling people about the [...] ---Outline:(01:18) The Simple Pipeline(04:26) The Spectre(09:38) Conclusion --- First published: February 21st, 2026 Source: https://www.lesswrong.com/posts/LuAmvqjf87qLG9Bdx/the-spectre-haunting-the-ai-safety-community --- Narrated by TYPE III AUDIO.

Chad and Jordan discuss news in the running back market, and quarterback trades for some depressed assets.Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

The UK chemical industry needs more swift and powerful regulatory support to save it from further erosion as production falls by more than half compared to 2021 levels. -          25 UK chemicals closures since 2021, country now only has one cracker-          Massive social impact of closures, often in deprived areas-          UK no longer produces some critical chemicals-          Lost UK chemical production could reach 55-60% from 2021 levels-          UK needs much more powerful government policy shift to save industry-          UK chemicals sees toughest business environment for many years-          Slight pick up expected in 2026-          For 2026, chemicals output forecast to contract in US, tepid growth in Europe, China-          India forecast 7% in chemicals output for 2026-          More protection needed against China, which has moved up the chemicals value chain and subsidises productionIn this ICIS Think Tank podcast, Will Beacham interviews Stephen Elliott, CEO of the UK Chemical Industries Association and ICIS market development director John Richardson.

This week on Socially Democratic, Stephen is joined by policy expert and Executive Director of the Chifley Research Centre, Emma Dawson.Emma joins the show to talk about what Labor's clear majority actually means, what they can still achieve in their second term, and whether this is a once-in-a-generation opportunity for structural reform.Emma brings her wealth of knowledge to the vital questions of 2026, including:

A thinktank called Labour Together, linked to Keir Starmer and Morgan McSweeney, has been exposed for investigating journalists who were looking into the group's funding. One of those journalists was the Guardian's Henry Dyer. He tells Helen Pidd how he found out and why it matters. Help support our independent journalism at theguardian.com/infocus

Jan Fischer ist Unternehmer und Stifter. Neben der LAS ART Foundation, die im vorangegangenen Podcast mit Bettina Kames vorgestellt wurde, hat er auch den mit 90.000 Euro dotierten Weststern-Förderpreis ins Leben gerufen. Gefördert werden damit jedes Jahr Kunstvereine in Nordrhein-Westfalen. An den Kunstvereinen schätzt Jan Fischer, dass sie „Experimentierräume“ sind, die neue Perspektiven auf die Wirklichkeit eröffnen, die lokale Kunstinfrastruktur stärken und das Bewusstsein weiten. Aber Jan Fischer, so erfahren die beiden Podcaster Torsten Fremer und Friedrich von Borries, fördert aber nicht nur Kunst, sondern engagiert sich mit dem von ihm ins Leben gerufenem „Zentrum für neue Sozialpolitik“, ein Think Tank mit Sitz in Berlin, der die Grundlagen für ein selbstbestimmtes Leben und mehr gesellschaftliche Teilhabe für alle wissenschaftlich erforscht und daraus, perspektivisch, Handlungsempfehlungen für die Politik ableiten will.

Immer am Wochenende: Die beiden meist gehörten Folgen des F.A.Z. Podcast für Deutschland vom Wochenende. Heute: Die Trump-Regierung plant, europäische ThinkTanks und NGOs finanziell zu unterstützen, um die politische Agenda der MAGA-Bewegung voranzutreiben. Wie reagieren die europäischen Rechtsaußenparteien, insbesondere die AfD, auf diese Entwicklung? Und welche Risiken birgt eine solche Unterstützung für sie?

Chad and Jordan react to the Super Bowl and the fallout early in the dynasty offseason.Plus massive dynasty trades.Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

EU and industry leaders meet in Belgium to call for urgent action to stop and reverse the erosion of the region's industrial value chains. -          New Antwerp meeting of industry leaders and EU leaders aims to speed up moves to save chemicals and other heavy industry-          Industry is in crisis and action is required right now to stop further deindustrialisation -          EU must move to a federal structure to allow for swift decision-making and more powerful tools to support it-          Coalition of the willing to get action without full consensus-          Rising tide of regulation needs to be reversed-          Criticism of member states for “gold-plating” EU regulations, adding new rules at national level-          Proper pan-European energy market is required-          Podcast was recorded on Thursday 12 February

Barbara Blaha ist Autorin, Medienarbeiterin und Influencerin, sie ist Gründerin des Momentum Instituts, einem progressiven Think-Tank, der unter anderem den Fokus auf Nachhaltigkeit und soziale Gerechtigkeit legt, sowie Universitätsrätin der Universität Wien und Mitgründerin des Wiener Balls der Wissenschaften. In ihrem neuen Buch „Funkenschwestern“ beschreibt Barbara Blaha, worin in den letzten 50 Jahren Fortschritte in der Gleichstellung der Geschlechter erzielt wurde und warum wir dennoch vom Ziel weit entfernt sind. In „Funkenschwestern“ benutzt Barbara Blaha zur Klärung dieser Frage Zahlen, Studien und Fakten und auch einige Blicke in die nähere und fernere Vergangenheit. Sie macht sichtbar, „warum Frauen seltener führen dürfe".Livegast in der heutigen HOT Sendung mit Melissa Erhardt: Barbara Blaha, Autorin und Gründerin des „Momentum“- Instituts, zu ihrem neuen Buch „Funkenschwestern - Wie Feminismus alles besser macht“.Sendungshinweis: FM4, HOT, 12.02.2026, 13 Uhr

Si l'intelligence artificielle est censée révolutionner nos vies, elle semble moins pressée pour bousculer les inégalités de genre. Selon les derniers chiffres du Forum économique mondial, les femmes ne représentent que 22% des effectifs travaillant dans l'IA. Et pour celles qui réussissent à se démarquer, à lancer leur start up, elles peinent à obtenir des financements.  Dans un monde où les algorithmes façonnent nos représentations, nos imaginaires mais aussi l'accès à l'emploi, au financement ; cette faible part des femmes n'est pas sans conséquence. Car si les hommes et notamment les hommes blancs, conçoivent les technologies, ils influencent inconsciemment ou pas les choix techniques, les priorités de développement, et de l'autre côté de l'écran, nos usages. Les IA sont donc loin d'être neutres. Cette absence des femmes n'est pas née avec l'intelligence artificielle. Si elles étaient majoritaires dans l'informatique jusqu'aux années 1970, le secteur a vu affluer les hommes en masse avec l'avènement du génie logiciel et des micro-ordinateurs. Dans ce contexte, comment décoder les biais de genre et raciaux véhiculés par les intelligences artificielles et comment faire des femmes des utilisatrices averties et des conceptrices des technologies ?    Émission à l'occasion de la journée internationale des femmes et des filles de science.  Avec :  • Estelle Ndjandjo, journaliste et présentatrice de la chronique Voisins connectés, diffusée chez 8 milliards de voisins.   Et nos invitées :  • Marion Carré, experte en IA, cofondatrice de Ask Mona, une entreprise qui marie culture et intelligence artificielle et auteure de Qui a voulu effacer Alice Recoque ? - Sur les traces d'une pionnière oubliée de l'IA (Fayard, 2024) et Le paradoxe du tapis roulant - Vaincre notre paresse intellectuelle face à l'IA (J.-C. Lattès, 2025) • Pamela Corbin-Audoux, experte diversité et inclusion. Membre du Think Tank, Les EnthousIAstes sur l'IA dans les RH.    En fin d'émission, la chronique de Jennifer Lufau nous fait découvrir des femmes qui ont marqué l'histoire du gaming et de la technologie. À commencer par un film qui cristallise bien les difficultés mais aussi la résilience des femmes dans la tech, Hidden Figures ! Une fiction du cinéma hollywoodien qui raconte l'histoire de femmes afro-américaines embauchées dans les années 60 par la NASA pour être des calculettes vivantes, tout ça en pleine guerre froide.  Programmation musicale :  ► Fāfaru - 15 15  ► « Intro (Simone Simone) » - Joyce Babatunde.

Si l'intelligence artificielle est censée révolutionner nos vies, elle semble moins pressée pour bousculer les inégalités de genre. Selon les derniers chiffres du Forum économique mondial, les femmes ne représentent que 22% des effectifs travaillant dans l'IA. Et pour celles qui réussissent à se démarquer, à lancer leur start up, elles peinent à obtenir des financements.  Dans un monde où les algorithmes façonnent nos représentations, nos imaginaires mais aussi l'accès à l'emploi, au financement ; cette faible part des femmes n'est pas sans conséquence. Car si les hommes et notamment les hommes blancs, conçoivent les technologies, ils influencent inconsciemment ou pas les choix techniques, les priorités de développement, et de l'autre côté de l'écran, nos usages. Les IA sont donc loin d'être neutres. Cette absence des femmes n'est pas née avec l'intelligence artificielle. Si elles étaient majoritaires dans l'informatique jusqu'aux années 1970, le secteur a vu affluer les hommes en masse avec l'avènement du génie logiciel et des micro-ordinateurs. Dans ce contexte, comment décoder les biais de genre et raciaux véhiculés par les intelligences artificielles et comment faire des femmes des utilisatrices averties et des conceptrices des technologies ?    Émission à l'occasion de la journée internationale des femmes et des filles de science.  Avec :  • Estelle Ndjandjo, journaliste et présentatrice de la chronique Voisins connectés, diffusée chez 8 milliards de voisins.   Et nos invitées :  • Marion Carré, experte en IA, cofondatrice de Ask Mona, une entreprise qui marie culture et intelligence artificielle et auteure de Qui a voulu effacer Alice Recoque ? - Sur les traces d'une pionnière oubliée de l'IA (Fayard, 2024) et Le paradoxe du tapis roulant - Vaincre notre paresse intellectuelle face à l'IA (J.-C. Lattès, 2025) • Pamela Corbin-Audoux, experte diversité et inclusion. Membre du Think Tank, Les EnthousIAstes sur l'IA dans les RH.    En fin d'émission, la chronique de Jennifer Lufau nous fait découvrir des femmes qui ont marqué l'histoire du gaming et de la technologie. À commencer par un film qui cristallise bien les difficultés mais aussi la résilience des femmes dans la tech, Hidden Figures ! Une fiction du cinéma hollywoodien qui raconte l'histoire de femmes afro-américaines embauchées dans les années 60 par la NASA pour être des calculettes vivantes, tout ça en pleine guerre froide.  Programmation musicale :  ► Fāfaru - 15 15  ► « Intro (Simone Simone) » - Joyce Babatunde.

DGS Think Tank with Rasheen Aldridge & Kurt Bahr- h4 full 1048 Tue, 10 Feb 2026 22:35:12 +0000 tdkigOYC9gWVvSKKBV2QosQeRaGPx8wE comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government DGS Think Tank with Rasheen Aldridge & Kurt Bahr- h4 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False https://player.amperwavepodcasting.com?f

Steve, Justine, Tim, Katie & Matt M. get into a think tank for ideas for the ABV Barrel Shop. TBD music by Kevin MacLeod (incompetech.com).   Important Links: Patreon: https://www.patreon.com/theabvnetwork Our Events Page: bourbonpalooza.com Check us out at: abvnetwork.com. The ABV Barrel Shop: abvbarrelshop.com   Join the revolution by adding #ABVNetworkCrew to your profile on social media.

MrBeast Industries kauft die Gen-Z-Banking-App Step Mobile – ist das die Zukunft der Influencer-Monetarisierung? Amazon baut einen KI-Content-Marketplace, um Publisher am Leben zu halten. Die EU warnt Meta: WhatsApp darf keine Chatbot-Konkurrenten mehr blockieren. OpenAI feiert 10% Wachstum im Januar. Der Software-Ausverkauf trennt Spreu vom Weizen: Monday.com verliert 20%, Datadog gewinnt 15%. Spotify überrascht mit starken Zahlen. Frank Thelen behauptet in einem Podcast, er hätte "oft 1000x" mit Investments gemacht. Die USA wollen MAGA-nahe Think Tanks und NGOs in Europa finanzieren. Die Trump-Familie hat bereits 1,4 Milliarden Dollar aus World Liberty Financial gezogen. Und Taiwan-Chips werden von US-Zöllen ausgenommen. Unterstütze unseren Podcast und entdecke die Angebote unserer Werbepartner auf ⁠⁠⁠⁠⁠doppelgaenger.io/werbung⁠⁠⁠⁠⁠. Vielen Dank!  Philipp Glöckler und Philipp Klöckner sprechen heute über: (00:00:00) Intro (00:03:06) MrBeast kauft Step Mobile Banking App (00:06:04) Influencer-Monetarisierung: Infrastruktur statt Merch (00:11:56) Amazon baut KI-Content-Marketplace (00:14:49) EU warnt Meta: WhatsApp blockiert Chatbots (00:18:02) OpenAI feiert 10% Januar-Wachstum (00:21:06) Monday.com Earnings (00:38:13) Datadog Earnings (00:39:14) Spotify Earnings (00:42:06) Frank Thelen: Die 1000x-Lüge im Faktencheck (00:54:11) USA finanzieren MAGA-NGOs in Europa (01:00:42) Eric Schmidt datet Söder-Tochter (01:05:20) Krypto: Tether & World Liberty Financial (01:16:30) Taiwan-Chips von US-Zöllen ausgenommen Shownotes MrBeast's Beast Industries to Buy Gen Z–Focused Banking App - theinformation.com Amazon Discusses AI Content Marketplace With Publishers - theinformation.com Update: ChatGPT & Google dropped Grokipedia. - linkedin.com Sam Altman lobt ChatGPTs Wachstum bei OpenAI's $100 Milliarden Finanzierung. - cnbc.com Meta von EU aufgefordert, WhatsApp für Rivalen zu öffnen. - bloomberg.com Monday.com drops 21% as AI disruption fears mount in software - cnbc.com Datadog ist heute Spitzenreiter im S&P 500. - barrons.com Spotify pops 16% on strong user growth, earnings beat - cnbc.com {ungeskriptet} Frank Thelen Podcast - open.spotify.com US government to fund Maga-aligned think-tanks and charities in Europe - ft.com Krypto-Riese Tether half Türkei bei Milliardenschlag gegen Betrug. - bloomberg.com Eine Generation regiert, die nächste profitiert von Krypto. - wsj.com US Tarifs chips Ausnahme - ft.com

Chad and Jordan react to the Josh Allen foot injury, Dalton Kincaid's PCL tear, and dynasty trades.  Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

Conversations on Groong - February 5, 2026Topics:Defining the “Canceling Russia” phenomenonThe “cancel Russia” lobbyContainment shifts to coercive transformationRussian Orthodox Church as battlegroundKremlin “towers” and civilizational logicBooks by Tsygankov:“Canceling” Russia (2026): https://a.co/d/0izauT7TRussia's Foreign Policy (2025): https://a.co/d/07NNNT6dGuest: Andrei TsygankovHosts:Hovik ManucharyanAsbed BedrossianEpisode 514 | Recorded: February 4, 2026SHOW NOTES: https://podcasts.groong.org/514VIDEO: https://youtu.be/WOLR5AuizEQ#CancelingRussia #RussianForeignPolicy #UkraineWar #StateCivilization #TowersOfTheKremlin #RussianOrthodoxChurchSubscribe and follow us everywhere you are: linktr.ee/groong

Kiera is joined by the tooth-healer himself, Jason Dent! Jason has an extensive background in pharmacy, and shares with Kiera where his pharmaceutical experience has bled over into dentistry. This includes the difference between anti-quag and anti-platelet and which medications are probably safe, what to do to shorten the drag time in the pharmacy, how to write prescriptions most efficiently, and more. Episode resources: Subscribe to The Dental A-Team podcast Schedule a Practice Assessment Leave us a review Transcript: The Dental A Team (00:00) Hello, Dental A Team listeners. This is Kiera and today is a really awesome and unique day. It is, think the second time I've had somebody in the podcast studio with me live for a podcast and it's the one and only Jason Dent. Jason, how are you? I'm doing well. Good morning. Thanks for having me. It is crazy. I I watch Instagram real like this all the time where people are like in the podcast and they're hanging out on two chairs and couches and now look at us. We're doing it. Cheers. Cheers.   That was a mic cheer for those of you who are only listening, but yeah, Jace, how does this feel to be on the podcast? It's weird. Like I was not nervous at all talking about it. I got really nervous as soon as you hit play. So if I stumble over my words, please forgive me ahead of time. Well, Jason, I appreciate you being on the podcast because marketing had asked me to do a topic about teledentistry and I was like, oh shoot, that's like not my forte at all. so   You and I were actually chatting in the hot tub. call it Think Tank session and you and I, we have a lot of good ideas that come from that Think Tank. A lot of business. no phones. That's why. We do leave our phones out. But I was talking to Jason and this is actually a podcast we had talked about quite a while ago. Jason has a lot of information on pharmacy. And if you don't know, Jason isn't really, we were going through all of it last night. It's kind of a mock in the tub. And I think it's going to be great because I feel like this is an area, I'm working at Midwestern and   knowing about how dentists, pharmacology was surely not your favorite one. Jason actually helps a lot of dentists with their clearances. And so we were talking about it and I like it will just be a really awesome podcast for you guys to brush up on pharmacology, different things from a pharmacist's side. So Jason, welcome. Thank you. Yeah, no, we were talking about it and here's like, what should I talk about on the podcast next? I have all these different topics and she's like, what do you know? And the only real interaction I have with dentists is doing clearances for procedures. We get them all the time, which makes sense.   Lots of people are on blood thinner, I've always told Kiera, like, hey, I could talk about that. Like, that's kind of a passion of mine. I'm not a dentist. Or my name is Jason Dent. So in Hebrew, Jason means tooth. No, no, no, sorry. Nerves are getting to me. Jason means healer and Dent means tooth. So my name means tooth healer. So, here's a little set. Hold on, on, hold Can we just talk about? I brought that up before you could talk about it more. So.   My name means tooth healer but I did not become a dentist. I know you wanted me to become a dentist. did. I don't know why. I enjoy medicine. I know what you're going to get to already. The things you're going to ask me. There's been years of this. But nevertheless, that's my name. We'll get that out of the way. But you did give me a great last name. So I mean, it's OK. You're All is fair and love here. SEO's up for that. But yeah, Jason, I'm going to get you right into the show. And I'm going to be the host. And we're going to welcome to the podcast show. Jace, how are you?   Good, good, good. Good, good, good. So by getting into clearances, right? This is what you're kinda talking about with you know, before we get to clearances, I actually wanted Jason, for the listeners who don't know you, who haven't talked to you, who don't know, let's kinda just give them like, how did you go from, Kiera wanted you to be a dentist, to now Jason, you are on the podcast talking as our expert on pharmacy. fantastic. I've always really loved medicine, a ton. As a kid getting headaches and taking Excedrin, like you just feel like a miserable pile of crap.   and then you take two pills and all of a sudden you feel better. Like that's amazing, like how does that happen? Also getting ear aches as a kid, just being in so much pain and then taking some medicine and you start feeling a lot better. I always had a lot of appreciation for that. I've always been mechanically inclined. I went to, started doing my undergrad and took biology and learned about ATP synthase, which is a spinning enzyme that's inside the mitochondria, like a turbine engine. I used to work on small engines on my dirt bike and thought that is so cool. So I really got wrapped up into chemistry.   All the mechanics of chemistry really pulled me in. I'm not getting goosebumps. checking. I usually get goosebumps when I think about chemistry. But it's so cool. You think an engine's awesome, like pistons and camshafts and pressures, the cell is the same thing. It's not as loud, so it's not as cool. But it's fascinating. that's why we're like. ⁓   chemistry and really got into coagulation. So I did my residency after pharmacy school. we went to Arizona for three years. ⁓ You did and your main focus, you were never wanting to be the guy behind the counter. No, I haven't done that. Yeah. No, I love them though. I've always really want to go clinical. ⁓ But I love my retail ⁓ pharmacists. They're amazing resources. And ⁓ I use the retail pharmacist every day still to this day, but I went more the clinical route, really love the chemistry aspect of it.   did my doctorate degree and then I did my residency in Reno. Reno's kind That's how we got here everybody. Welcome to Reno. Strategically placed because I was really interested in critical medicine and where we're located we cover a huge area. So we pull in to almost clear, we go clear to Utah, clear to California, all of Northern Nevada. We get cases from all over. So we actually are kind like the first hub of care for lot of areas. So we really get an eclectic mixture of patients that come in that need-   all kinds of different cases that are coming to them. So it's what I really wanted. So I did my residency in critical care there. And then for the next 10 years, I worked in vascular medicine with my final five years being the supervisor of the clinic. Ran all the ins and outs of that. So my providers, two doctors were on our view. So when we talk about dentistry, talk about production, those kinds of things, totally get it. My doctors were the exact same way, my vascular providers. ⁓   There's some pains there, right? You wanna be seeing patients as much as possible, being able to help as many people, keeping the billing up. And had other nurse practitioners, four practitioners, a fleet of MAs, eight pharmacists. We also had that one location we had, going off the top of my head, I think we had eight locations running as well. And we took care of all the different kinds of vascular cases that came to us. Most common was blood clots, ⁓ which is just a...   which is an easier way of saying VTE. There's so many different ways to say a blood clot. Like you might hear patients say, I've had a PE or a DVT or a venous thromboembolism or a clot in my leg, right? They're all clots, but in different locations. Same with an MI, and MI can be a clot as well. ⁓ there's a lot of, everybody's kind of saying the same thing, but sometimes the nomenclature can make it sound hard, but it really is actually pretty simple.   No. And Jason, I love that you went through, you've been in like, and even in your, ⁓ when you were getting your doctorate, you were in the ER. You also worked in retail pharmacy. remember you having a little sticker on your hand. And retail pharmacy, I have a lot of respect for those guys. They have a lot of pressure on them. and then you also, ⁓ what was that test that you had to take that? I don't know. You were like studying forever for it. ⁓ board certification for, ⁓ NABP. Yeah. So I did that board certification as well.   And now you've moved out of the hospital side onto another section in your career. Now in the insurance, right? So it's really, really interesting. So now I'm on the other side reading notes and evaluating clinical appropriateness and trying to help patients with getting coverage and making those kinds of determinations. So yeah, I've really jumped all over. Really love my clinical days. I know. don't I don't I do miss them. But yeah, kind of had a good exposure to a lot of.   pharmacy a lot a lot of dentists actually with all the places that come through which Jason I really appreciate that and honestly I know you are my spouse and so it's fun to have you on but when I go into conversations like this I don't know any of this information and so finding experts and Jason I think here's me talk more about dentistry and my business than I do hear about him on pharmacy so as we were chatting about this I really realized you are a wealth of knowledge because you've been on the clinical side so you've done a lot of patient care and you've seen how   medications interact and I know you've had a few scares in your career and ⁓ you've known some physicians that have had a few scares and ⁓ you've seen plenty of patients pass away working in the ER and gosh in Arizona drownings were such a big deal. I remember when you were in the ER on your rotations I'd be like who died today? Like tell me the stories and you've really seen and now going on to the insurance side I felt like you could just be such a good wealth of knowledge because I know dentists are sometimes so   I would say like maybe just a little more anxious when it comes to medications. I know that dental students from Midwestern were like here was like four months and we had to like pass it, learn it. And Jason, you've done four years plus clinical residency, plus you've been in it. And something I really love about Nevada Medicine is they've been so collaborative with you.   like your heart, your cardiologist, they diagnose and then they send to you to treat with medicine and... Yeah, I've been really lucky being here in Reno too. The cardiology team has been amazing to work with. We started a CHF program, sorry, congestive heart failure program for patients. So we would collaborate with cardiologists. They'd see the cardiologists and then they send them to the pharmacist to really manage all the medications. So there's pillars of therapy ⁓ called guideline directed medical therapy and the pharmacist would take care of all that. So that's gonna be your...   your beta blockers, your ACEs, your ARBs, your Entresto, which would be a little bit better, spironolactone. So just making sure that all these things are dosed appropriately, really monitoring the heart, and make sure that patients are getting better. we've had real positive outcomes when the, sorry, this is totally off topic. do, talk about that study. When we looked at when patients were coming to see our pharmacists in our clinic that we started up, the patients were half as likely to be readmitted. And this was in 2018, and our pharmacists,   We're thinking about all the medications. We're usually adjusting diabetes medications too at the same time. Just kind of naturally just taking care of all the medications because we kind of got a go ahead from the providers, a collaborative practice agreement that we could make adjustments to certain medications within certain parameters. So we weren't going rogue or maverick, but we were definitely trying to optimize our medications as much as possible. And then years later, some studies came out with, I'm sure you've seen Jardins and Farseegh. not trying to, I'm not.   I don't get any kickback from them. I have no conflicts to share. But because our pharmacists were really optimizing that medication, those medications were later shown to reduce hospitalizations and heart failure, even though they're diabetes medications. Fascinating. So it wasn't really the pharmacists. It was just the pharmacists doing as much as they can with all the tools that were in front of them. And then we found out that the patients were going back to the hospital.   half as much as regular patients. So, yeah, being here, it's been so amazing to work with providers here. the providers here want help, want to help patients, don't have an ego. I mean, I just, it's awesome. I love it. I do love how much I think Jason sees me geek out about dentistry and I watching Jay's geek about his pharmacy and how much he loves helping patients. And ⁓ really that was the whole idea of, all right.   Dentistry has pharmacy as a part of it. And I know a lot of dentists are sending in clearances and I know working in a chair side, it would be like, oh no, if they're on warfarin or on their own blood clot, you guys, honestly don't even know half of what I'm talking about because this is not my jam, which is why Jason's here. But I do know that there was always like, well, we got to talk with their provider. And so having Jason come in and just kind of explain being the pharmacist that is approving or denying or saying yes or no to take them off the blood thinners in different parts, because you have seen several dental   I don't know what they're called. What is it? Clarence's? that what comes to you? don't even know. All day my mind, it's like, here is the piece of paper that gets mailed to you to the pharmacist and then you mail it back. So whatever that is. But Chase, let's talk about it because I think you can give the dentist a lot of confidence coming from a pharmacist. What you guys see on that side. When do you actually need to approve or disapprove? Let's kind of dig into that. Yeah. Well, first of all, I think I'm not a replacement for any kind of clinical judgment whatsoever. Every patient's different. But the American Diabetes Association, you   I work with diabetes a lot. American Dental Association has some really great guidelines on blood thinners and I would always reference them. I actually looked at their website today. Make sure I'm up to speed before I get back on this again. They have resources all around making decisions for blood thinners. And I think the one real important thing in putting myself in the shoes of a dentist or any kind of staff that's around a patient that's in a chair, if they say I'm on a blood thinner, right, a flag goes up. At least in my mind, that's what goes up.   Like, okay, how do we get across this bridge? And I think the important thing to really distinct right then when they say they're on a blood thinner is that is kind of a slang word for a lot of different medications, right? Like it's the overarching word that everybody pulls up saying, I'm on a blood thinner. It's like, okay, but I don't know what say. It's like, I have a car. You're like, okay, do you have a Mazda? Do you have?   Toyota, Honda, what do you have? or even worse it'd be like saying I have a vehicle, right? So when somebody says they're on a blood thinner, it opens up a whole box of possibilities of what they're Blood thinners are also, doesn't, when they're taking these types of medications that are quote unquote a blood thinner, it doesn't actually thin the blood, like adding water to the blood, if that makes sense, or like thinning paint, or like thinning out a gravy, right? It doesn't do the same thing. Blood thinners, really what they're doing is they're working on the blood, which.   which is really cool, try not to tangent on that. ⁓ When they're working on the blood, it's not thinning it per se, but it's making it so that the proteins or platelets that are in it can't stick together and make a cloth quite as easy. So whenever somebody's on a blood thinner, I usually ask, what's the name of the blood thinner that you're on? It's not bad that they use that slang, that's okay, on the same page, but it's really broken into two different classes. There's anticoagulant and antiplatelet.   And a way to kind of remember which is which, when residents would come through our clinics, the way that I teach them is a clot is like a brick wall. You know, it's not always a brick wall. Usually the blood is a liquid going through. But once they receive some kind of chemical message, it starts making a brick wall with the mortar, which is the concrete between the and the bricks, the two parts. When it's an anti-quagent, it's working on that mortar part. When it's an anti-platelet, it's working on the bricks part, right? You need both to make a strong clot or strong brick wall.   But if you can make one of them not work, obviously like if your mortar is just water, it's not working, right? You're not gonna make a strong brick wall. So that's kind of the two deviants right there. So that's what I do in my mind real quickly to find out because antiplatelets are usually, so that's gonna be like your Plavix, Ticagrelor, Brilinta. And hold on, antiplatelets are bricks? Good job, bricks. They're the bricks. And so the reason I was thinking you could remember this because I'm, antiplatelets, it's a plate and a plate is more like a brick.   And anti coagulant, I don't know why quag feels like mortar to me, like quag, like, know, it's like slushy in the blood, like it's coagulating. It's a little bit of that, like, honestly, I'm just thinking like coagulated blood is a little bit more mortar-ish. And so platelet is your plate, like a brick, and anti-quag is like.   the gilly between the bricks. Okay, okay, I got it. Yeah, so there's an exception to every rule, but when they're on that Don't worry, this is Kiera, just like very basic. You guys are way smarter listening to this, and that's why Jason's here. No, no, you helped me pass pharmacy school. When we were doing all the top 200, you helped me memorize all know what flexorill is, all right? That's a muscle relaxant. Cyclo? I don't know that part. It's a cyclo, because you guys are cycling and flexing. I don't actually know. just know it's a muscle relaxant, so that's about as far as I got. When we're looking at antitick platelets, so that's the brick part, so that's going to be your, you know,   Hecagrelor, Breitlingta, Clopidogrel is the most common one. It's the cheapest one, so probably see that one the most. Those, I mean, there's an exception to every rule, but that's generally being used after like a stent's placed in the heart. It can be used for VTE, there's some out there, but that's pretty rare. But also for some valves that are placed in the hearts, it can be used for that as well. So antiplatelet, really thinking more like a cardiac event, right? Like I said, there's always an exception to every rule, but that's kind of where my mind goes real quickly, because we're gathering information from the patient.   They're on anticoagulant. Those are like going to be the new ones that you see commercials for all the time. So Xeralto, Alequis, those are the two big ones right now. They're replacing the older one. And also we were supposed to do a disclaimer of this is current as of today because the ADA guidelines do change. this will be current as of today. And Jason, as a pharmacist, is always looking up on that. I had no clue that you are that up to speed on dental knowledge. so just throwing it out there that if you happen to catch his podcast,   a few years back that obviously check those guidelines for sure. But the new ones are the Xarelto and Eloquist. They're replacing the older ones of warfarin. Warfarin's been around for a really long time. We've seen that one. Those are anti-coagulants. So when you're looking, when a patient says that, generally they're on that medication because they've possibly had a clot in the past or they have a heart condition called atrial fibrillation. Those are kind of the two big ones. Like I said, there's always caveats to it, but that's kind of where my mind goes real quickly. And then,   as far as getting patients cleared, the American Dental Association has really good resources on their website. You can look at those and they're always refreshing that up. They even say in their own words that there's limited data around studying patients in the dental chair and with anticoagulants or anti-platelets. It's pretty limited. There's a few studies, some from 2015, some from 2018. There's one as recent as 2021, which is nice. But really, all of those studies come together and it's really more of an expert consensus.   And with that expert consensus, they have kind of simplified things for dentistry, which is really nice. ⁓ comparing that to, we have more data for like total hip replacement, total knee replacement. We have a lot of data and we know really what we should be doing around then. But going back to dentistry, we don't have as much information, so they always say use clinical judgment, but they do give some really great expert guidance on that. So if a patient's on an anticoagulant, ⁓   they generally recommend that it doesn't need to be stopped unless there's a high bleeding risk for a patient. as a provider or as a clinician in the practice, you can be looking at high bleeding risk. Some things that make an oral procedure a little bit lower risk is one, it's in the compressible site, right? Like we can actually put pressure on that site. That's the number one way to stop bleeding is adding pressure. It's not like it's in the abdominal cavity where we can't get in and can't apply pressure. So number one, that kind of reduces the bleeding risk.   is number one. Two, we can add topical hemostatic agents. Dentists would know that better than me. There's a lot of topical ways to do that. So not only pressure, but there's those things as well. And also, but there are some procedures that are a little bit more likely to bleed. And that's where you and dentists would come in hand in What's the word in APO? Oh, the APOectomy. I got it right. Good job. like, didn't you tell me last night that the ADA guideline was like what?   three or four or more teeth? great question. So you can extract one to three teeth is what their expert consensus One to three teeth without. Without really managing or stopping anticoagulation or doing anything like that. I think that's some good guidance from them. I'm gonna add a Jasonism on that though. So with warfarin, I do see why dentists would be a little bit more conservative or worried about stopping the warfarin because warfarin isn't as stable as these newer agents. Warfarin, the levels.   quote unquote levels can go really high, they can go really low. And if the warfarin levels are high, they're more likely to bleed. So I do think it makes sense to have a really recent INR. That's how we measure what the warfarin's doing. I think that makes a lot of sense, but the ADA guidelines really go into the simplification version of all these blood thinners. Generally, it's recommended to not stop them because the risk of stopping them outweighs the benefit of stopping them in almost every case. Almost every case.   ⁓ So when you're with that patient, right, they say I'm on a blood thinner, finding out which kind of blood thinner that they're on, you find out that they're on Xeralto, right? How long have you been on Xeralto for? I've been on it for years. You don't know exactly why, but if they haven't had any recent bleeding, you're only gonna remove one tooth. ⁓ You can do what's called a HasBlood score. That kind of looks at the bleeding risk that they'd have. That'd be kind of going a notch above, but in my mind, removing one tooth isn't a real serious bleeding risk. I'd love to hear from my dentist friends if they...   disagree, right, but ADA says one to three tooth removals, extractions, that's the fancy word. Extractions, yeah, for extracting teeth out. Is not really that invasive. Sure. It's not that high risk, so it's usually perfectly fine. So if a patient was on Xarelto, ⁓ no other, this is in a vacuum, right? I'm not looking at any other factors, which you should be looking at other factors. I would be perfectly fine to just remove one to two.   And when those clearances come in, because dentists do send them, talk about what happens. You guys were working in the hospital and you guys would get these clearances all the time. do. We get them so often. I mean, we get like four or five a day. We'd love to give it to our students, student pharmacists, and ask them what to do. And they would usually look up the American Dental Association guidelines and come up with something. We're like, yep, that's what we say too. In fact, we say it so many times a day that we have a smart phrase.   which just blows in the information real quickly and faxes it right back to the So it's like a copy paste real quick. So what I wanted to point out when Jason told me this is dentists like hearing this and learning this, this can actually save you guys a ton of time to be able to be more confident, to not need to send those clearances on. And we were actually talking last night about how I think this might be a CYA for dentists. like, as we were talking, I think Jason, you seeing so many other aspects of medicine, like you've literally seen patients die, you've seen other areas.   And so coming from that clinical vantage point, we were realizing that dentists, we are so blessed to live in an injury. I enjoy dentistry because possibly there's someone dying, not super high, luckily in dentistry. The only time that I have actually had a doctor have a patient pass away, and it was only when they were completely sedated and doing ⁓ some other things, but that was under the care of an anesthesiologist. And so that's really our high, high risk. And so hearing this, Jason,   That was one of the reasons I wanted him to come on is to give you doctors more confidence of do we have to always send to a pharmacist? I mean, hearing that on the pharmacy side, they're just sending these back and not to say to not see why a to not cover this because you might be questioning like, well, do I really need to? But you also were talking about some other ways of so number one, you guys are just going to copy back the 88 guidelines. So so 88 guidelines. Yeah. And I think that that gives a lot of confidence to a provider or a dentist is that you can go to the 88 guidelines and read them, right? Like you're listening to some   nasally monotone pharmacist on a podcast. Rumor has it, people love him at the hospital. were like, you're the voice, he's been told he has a good radio So for the clinic, I was the voice. Like, yeah, you've reached the vascular clinic, right? And they're like, oh my gosh, you're the voice. But sorry, you me distracted. That'll be your next career, Jace. You're going to be a radio host. OK. I would love that. I love music. But you're hearing from a nasally guy, but you can actually read the ADA guidelines. You just go right to the ADA, click on Resources, and under Resources, it has the   around anticoagulants, I think that's the best way to get a lot of confidence about it because they have dentists who are the experts making calls on these. I'm just reiterating what they say, but I think it makes a lot of sense to help providers. And the reason why my heart goes out to you as well is having the providers that used to work underneath me, they're always looking for our views, which is a fancy way of making sure that they're drilling and filling. Can I say that? Yeah, can say drilling and filling. They're being productive, right? They're being productive, right?   They're always looking to make sure if a patient's canceling, like get somebody in here. Like I need to be helping people all day long. That's how I, we keep the lights on. That's how I help as many people. And so if you have a patient coming in the chair and it has an issue, they say I'm on Xeralto. Well, you can ask real quickly, why are you on Xeralto? I had a clot 10 years ago. my gosh. Well, yeah, we're pretty good to go. Then I'm not worried. We're only removing one tooth or we're just doing a cavity or a cleaning. Something like that. Shouldn't be an issue whatsoever because there's experts in the dental. ⁓   in the dental society, the ADA guidelines that recommend three teeth or less, minimally invasive. They really recommend if it's gonna be really high bleeding risk. And clinically, that's where you would come in, ⁓ or yourself. know, apioectomy is one that's like on the fence line. I don't know where implants set. though, and like we were talking, implants aren't usually like a date of procedure. Most people aren't popping in, having tooth pain, and we're like, let's do an implant. Now sometimes that can be the case, but typically that one's gonna have   a few other pieces involved. And so that is where you can get a clearance if you want to. ⁓ But we were really looking at this of like so many dentists that I know that you've seen will just send in these clearances because they are. And I think maybe a way to help dentists have more confidence is because you know, I love routines. I love to not have to remember things. So why don't we throw it in, have the team member set it up where every quarter we just double check the ADA guidelines. Are there any updates? Are there any other things that we need to do on that? That way you can just see like   getting into the language of this, of what do I need to do? Because honestly, you guys, know pharmacy was not a big portion for it, so, recommending different parts, but I think this is such a space where you can have confidence, and there's a few other things I wanna get to, and I you- I some pearls too. Okay, go. I'm so when she get me into talking about drugs, I'm not gonna stop. So, some other things around that too is these newer blood thinners like Xarelto Eloquist, they now have reversal agents, so a lot of providers in the past were really worried about bleeding because we can't turn it off. We can turn those off. Warfarin has reversal as well, right?   So I'm looking at these patients. It's really low risk. It's in the mouth, generally speaking. Very rarely are they a high bleeding risk. Now if you're doing maxillofacial surgery, this does not apply, right? This does not apply whatsoever. you're like general dentist, you're pediatric dentist. Yeah, yeah, and it's kind of on the fly. So just trying to really help you to be able to take care of those patients on the moment, have that confidence, look at the ADA guidelines, have that in front of you. I don't think it's a bad thing to ever...   check with their provider if you need to. If you're thinking, I feel like I should just check with the provider, I would never take that away from you. But I just want to kind of steer towards those guidelines that I have to help. But what did you want to share? No, yeah, I love that. And I think there were just a few other nuggets that we were chatting about last night that can help dentists just kind of get things passed a little bit easier. So you were mentioning that if they were named to their cardiologist, what was it? was like, who is the last? Great question. Yeah, when a patient's on a blood thinner,   It could be prescribed by the cardiologist. It could be prescribed by the family provider or could have been punted to like a vascular clinic like where I was working. It can go to any of those. And when you send that fax, right, if it goes to the cardiologist and it's supposed to go to the family care provider, like it just kind of goes, goes nowhere, right, from there. So I think it's a really good idea to find out who prescribed it last. If the patient doesn't know who prescribed their blood thinner last, you can call their pharmacy. I call pharmacies all day long.   I have noticed in the last year, they are way easier to get a hold of, which has made my job a lot easier, working on the insurance portion. So reaching out to the pharmacy, finding out who that provider is and sending it to them, because they should be able to help with that. I thought that was a good shift in verbiage that you had of asking instead of like the cardiologist, because that's who you would assume was the one. But you said like so many times you guys would take care of them, and then they go back to family practitioner, and you guys would get the clearances, but you couldn't clear because you weren't overseeing. So just asking the patient.   who prescribed their medication for them last time. That way you can send the clearance to the correct provider. then- And they might not know. You know patients, right? They're like, I don't know, my mom's or else, I don't know who gave it to me. Somebody told me I need to be on this. But at least that could be another quick thing. And then also we were talking last night about-   ⁓ What are some other things that dentists can do when like writing scripts to help them get what I think like overarching theme of everything we discussed is one how to help dentists have less I think drag through pharmacy. ⁓ Because pharmacy can take a little while and so perfect we now know the difference between anti-quag and anti-platelet. We know which medications are probably safe. We know we can check the ADA guidelines so that we were not having to do as many clearances. We also know if they're on a medication to find out and we do need a clearance.   who we can go to for the fastest, easiest result. And now, in talking about prescriptions, you had some really interesting tips that you could share with them. Yeah, so with writing prescriptions, right, pharmacies are pharmacies. So I'm not gonna say good thing or bad thing. There are challenges working with pharmacies. I'm not gonna play that down at all. ⁓ If you're writing prescriptions and having issues and kickbacks from pharmacies, there's some interesting laws around ⁓ writing prescriptions. Say that you're trying to ⁓ prescribe   augmentin, you know, 875 BID, and you tell the patient, hey, I want you to take this twice a day for seven days, and then you put quantity of seven, because you're moving fast, right? You want it for seven days, quantity of seven. Quantity would actually be 14, right? It's not that big of a deal. Anybody with common sense would say if you're taking a pill for twice a day for seven days, you need 14 tablets. But LAHA doesn't allow pharmacists to make that kind of a change, unfortunately. They have to follow what you're saying there. So you're going to get a...   An annoying callback that says, you wrote for seven tablets. I know you need 14. Is that OK? Just delays things, right? So ⁓ I really like the two letters QS. That's Q isn't queen. S isn't Sam. Yeah. It stands for quantity sufficient. So you don't have to calculate the amount of any medication that you're doing. So for me, as a pharmacist, when I was taking care of patients, I hated calculating the amount of insulin they would need for an entire month. So I would say.   Mrs. Jones needs 15, I'd say 15 units ⁓ QD daily. ⁓ And then I say QS, quantity sufficient, ⁓ 90 day supply through refills. So the pharmacy can then go calculate how much insulin that they need. I don't have to even do that. So anytime you're prescribing anything, I like that QS personally. So that lets the pharmacy use ⁓ common sense, as I like to call it, instead of giving you a call. I think that's super helpful. I also thought of one thing too.   going back to blood thinners is when it's kind of like a real quick, like they're not gonna have you stop the blood thinner at all. like you're seeing if you can stop the blood thinner for a patient, there's some instances it's just not gonna happen. And that's whenever they've been, they've had a clot or a stroke or a heart attack within the last three months. Three months. Yeah, that's kind of like the.   Because so many people are like, they had a heart thing like six years ago. And so I think a lot of my dentists that I worked with were like, we got to stop the blood thinners. But it sounds like it's within three months. Yeah, well, I'm just the time. Like this is general broad strokes. What I'm just trying to say is when you want to expect a no real quick. Got it. Right. So because benefits of stopping a blood thinner within those first three months of an event is very, very risky versus the, you know, the benefit of reducing a little bit of blood coming out of the mouth. Right. Like that's not that bad.   when somebody's had a stroke or a heart attack or pulmonary embolism, a clot in the lung, like we can't replace the lung, heart or brain very easily. We can replace blood a lot better. We've got buckets of it at most hospitals have buckets of it, right? So I'm always kind of leaning towards I'd rather replace blood than tissue at all times. So that's kind of a quick no. If they've had one those events in the last three months, we are really, really gonna watch their brain instead of getting.   root canal, right? Like really worried about them. So you'll just say no. And they could the dentist still proceed with the procedure or would you recommend like a three month wait? Or is it provider specific way the pros and cons because sometimes you need to get that tooth out. Great question. think then it's going to come into clinical. That's that's when you send in the clearance, right? Like, and it's great to reach out to the provider who's managing it for you. But I think it's kind of good to know exactly when you get a quick no quick no is going to be less than three months.   ⁓ Or when it's going to be like a kind of a typical, yeah, no problem. If it's been no greater than six months, they're on the typical anticoagulants or alto eloquence. Nothing crazy is going on for them. You're only removing two teeth. This is very, very low risk. But again, I'd urge everybody to read the ADA guidelines. That way you feel more comfortable with it. I'm not as eloquent as they do. They do a real good job. So I don't want to take any of their credit. I think they do a real good job of simplifying that and making you feel confident with providing.   more timely care for patients. Which is amazing. And Jayce, one last thing. I don't remember what it was. You were talking about the DEA and like six month rule. yeah. Let's just quickly talk about that and then we'll wrap this because this is such a fascinating thing for me last night. Yeah. So when comes to prescribing controlled substances, most providers have to have a DEA license. OK. First of all, though, what's your take on dentist prescribing controlled substances? ⁓ I don't think, you know, I worked on the insurance side of things. Right. And I look at the requirements for the   as the authorizations, what a patient, the criteria a patient needs to hit in order to qualify for certain medications. A lot of times for those controlled substances, they have pretty significant issues going on, like fibromyalgia or cancer-related pain or end-of-life care versus we don't, in all my scanning thread, I don't have a ⁓ perfect picture memory. Sure. But I don't usually see oral.   pain in there. There is some post-operative pain that can be covered for those kind of medications but I really recommend to keep those lower and in fact in a lot of our criteria it recommends you know have they tried Tylenol first, they tried, have they filled NSAIDs or are they contraindicated with the patient. So really they should be last line for patients in my two cents but there's always going to be a caveat to the rule right? Of course. comes through that has oral cancer and you're taking   like that would make sense to me. Got it, so then back to the DEA. Yeah, okay. Okay, ready. So as a provider, you should be checking the, if you're doing controlled substances, you should be checking the prescription drug monitoring program, or sometimes called the PDMP, looking to see if patients are getting ⁓ controlled substances from another provider. So it's really just a check and balance to make sure that they're not going from provider to provider to getting too many narcotics and causing self harm or harm to others.   And so with checking that PDMP before prescribing, I think a lot of providers do that. A lot of softwares that I'm aware of, EMRs, electronic medical records, sometimes have links so that you can do that more quickly. However, I don't think it's as intuitive that they need to be checking that every six months in some states. And like here in Nevada, you're supposed to be checking it every six months, not for a patient, but for your actual DEA registration to see if anybody else is prescribing underneath you. Because if you don't check that every six months, you could get in some serious trouble with...   not only DEA, but even more the Board of Pharmacy and your state. Now, I don't know all 50 states, so I check with your state to see if you need to be checking that every six months, but set an alarm just to check that real quickly, keep your nose clean. ⁓ I've had providers, I've had to remind to do that. And if somebody was using your account, prescribing narcotics, you'd never know unless you went and checked that PDMP.   Yeah, I remember last night you were like, and if that was you, I would not want to be you. The Board of Pharmacy is going to be real excited to find you. So that was something where I was like, got it. So, and we all know I'm big on let's make it easy. And Jason, I love that you love this so much and you just brought so much value today. And like also for me, it's just fun to podcast. fun. Yeah. But I got a nerd out on my world a little bit. Bring it into yours. I work with dentists or at least you know, when I was working in Vascular Clinic all day long. Great questions that would come through. Yeah.   So I think for all of us, as a recap on this is number one, I think setting yourself ⁓ some cadences. So maybe every quarter we check our ADA guidelines and we check our, what is it, PDMP. PDMP. so each state, so they call it Prescription Drug Monitoring Program. We need that. Yeah, but there are different acronyms in different states, though. That's just what it's called in Nevada. I forget what it is in California, but you can check your state's prescription monitoring program, make sure that opioids aren't being prescribed under your name. Got it. So we just set that as a cadence.   We know one to three teeth most likely if they're on a blood thinner is According to the 88 as of today is good to go You know things that are going to get a quick know are going to be within the last three months of the stroke the heart attack or the Clot I'm thinking like the pulmonary embolus. Yeah, that's what we're trying to prevent   Those are gonna be quick knows and then if we're prescribing, let's do QS. We've got quantity is sufficient so that we're not getting phone calls back on those medications that we are. And then on narcotics, just being a bit more cautious. Of course, this is provider specific and in no way, or form did Jason come on here to tell you you are the clinical expert.   Jason's the clinical expert on medications. And if you guys ever have questions, I know Jason, you geek out and you want to talk to people so that anyone wants to chat shop. Be sure to reach out and we'll be able to connect you in. we've even talked about possibly, so let me know listeners. You can email in Hello@TheDentalATeam.com of ask a pharmacist anything. I talked to Jason. I was like,   We'll just have them like send in questions and maybe get you back on the podcast or we do a webinar. But any last thoughts, Jace, you've got of pharmacy and dentistry as we as we wrap up today? No, I think that's pretty much it. So check the ADA guidelines. I think it's really good to have cross communication between professions. Right. If you're working with the pharmacy, CVS, Walgreens or something like that or Walmart, I know that it can be challenging. Right. They're under different pressures. You're under different pressure. So I think ⁓ just coming in with an understanding, not being angry at each other.   you know what mean, is super beneficial and working together. When it comes to it, every dentist that I've talked to is actually worried about their patient. Every pharmacist that I've worked with is really worried about the patient as well. So we're trying to accomplish the same thing, but we have different rules and our hands are bound in different ways that annoy each other, right? Like I know Dr. Jones, want 14 tablets, but you said seven. And I know Common Sense says I should give them 14, but I've got to make that change.   knowing that their hands are tied by the law. They can't use as much common sense, which is aggravating. I mean, that's why I love what I gotta do here. I gotta just kind of help a lot more and use common sense and improve patient care. But those kinds of things I think are really beneficial as you work together and then not being so afraid of blood thinners, right? So I think those guidelines do a great job of giving you confidence and not worrying about the side effects. And there's a lot of things that you can do locally for bleeding.   You have a lot of control over that. I think that's pretty cool, the tools they have. Yeah. And at the end of the day, yes, you are the clinician. You are the one who is responsible for this. so obviously, chat, but I think collaborating, talking to other pharmacists, talking to them in your state, finding out what are the state laws, things like that I think can be really beneficial just to give you peace of mind and confidence. And again, dentistry, are maybe a bit more risk adverse because luckily we don't have patients dying That's great thing. Yeah, that's fantastic. I want my dentists to be risk adverse. I think so too. But Jason, I appreciate you being on the podcast today.   And for all of you listening, ⁓ more confidence, more clarity, more streamline to be able to serve and help our patients better. if we can help you in any way or you've got more questions, reach out Hello@TheDentalATeam.com. And as always, thanks for listening. I'll catch you next time on the Dental A Team podcast.  

Rex Miller is a keynote speaker, futurist, and executive coach who helps leaders and organizations unlock the hidden genius that lies just beneath the surface, often trapped by outdated systems, fear, or inertia. He is author of the book, "Genius Spark: Reignite Your Life" and Mike Petrusky references insights learned from Rex over the years as they discuss the challenges of remote and hybrid work today. They explore how workplace leaders should embrace differences and friction in their teams as they seek to drive innovation and improve employee engagement. Rex believes that curiosity and understanding are essential for effective collaboration and he shares practical tips for leaders hoping to move their organizations forward in our new world of work. Embracing a move from "think tank" to "do tank" is the call to action as Mike and Rex offer the insights and inspiration you need to be a Workplace Innovator! Connect with Rex on LinkedIn: https://www.linkedin.com/in/rexmiller/ Learn more about Genius Spark: https://rexmiller.com/genius-spark Discover free resources and explore past interviews at: https://eptura.com/discover-more/podcasts/workplace-innovator/ Learn more about Eptura™: https://eptura.com/ Connect with Mike on LinkedIn: https://www.linkedin.com/in/mikepetrusky/  

Learn more about your ad choices. Visit megaphone.fm/adchoices

Chad and Jordan react to the NFC championship, teambuilding, and dynasty trades of depressed value players.Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

Creepypasta Scary Story https://brett-schumacher-shop.fourthwall.com

Esperanza and Irwin delve deep into one of the most unknown of East End stories. The Lindisfarne Association (1972 -2012) was a nonprofit foundation and diverse group of intellectuals organized by cultural historian William Irwin Thompson for the "study and realization of a new planetary culture". With a cast of characters from the worlds of art, science, religion, poetry and medicine (including Dr. Jonas Salk), the collective brainpower was through the proverbial roof. And all of it on a campground at Fish Cove in North Sea, Southampton. Listening is Believing.

Ops Sindoor was a conflict that saw use of long range vectors, both air to air and air to ground along with massive use of drones, loitering munitions and air defence in play. ThePrint's Editor - Defence and Diplomacy Snehesh Alex Philip tells us more about a report on Ops Sindoor by Swiss military think tank Centre for Military History and Perspective Studies in #DefenceScope

Chad and Jordan discuss Zach Charbonnett's injury fallout and C.J. Stroud's market.Plus trades!Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

In this episode of Pekingology, CSIS Senior Fellow Henrietta Levin is joined by Sabine Mokry, Postdoctoral Researcher with the Institute for Peace Research and Security Policy at the University of Hamburg and author of the new book Chinese Scholars and Think Tanks' Construction of China's National Interest. Sabine unpacks the process through which outside expertise can shape the Party's national security concepts, the relevance of Chinese think tanks and scholars in policymaking, and how China – nearly a thousand miles from the Arctic – became a “near-Arctic State.”

The DGS Think Tank with Michael Butler & Steve Ehlmann- h4 full 1009 Tue, 20 Jan 2026 22:37:14 +0000 nlMs1lyCf2XfM6TA4eLgMILc2MMdWk47 comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government The DGS Think Tank with Michael Butler & Steve Ehlmann- h4 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False https://player.amperwavepodcasting

Chad and Jordan discuss the fallout from the first weekend of the NFL playoffs, George Kittle's injury, and risers/fallers from week one.  Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

India is entering an era where power no longer sits only in governments, elections, or visible institutions — it operates through deep systems, narratives, capital flows, intelligence networks, and corporate influence. In this wide-ranging and uncompromising conversation, former R&AW chief Vikram Sood ji explains how the deep state actually functions in the modern world — beyond conspiracy theories and political slogans. From intelligence agencies and NGOs to Big Tech, asset managers, media, and covert influence operations, Vikram Sood ji lays out how power sustains itself regardless of which government is in office. We discuss why wars no longer need victories, how narratives are manufactured to justify conflict, and why wealth — not ideology — has become the real source of global control. The conversation spans Pakistan, China, the United States, Europe, Ukraine, pandemics, Hollywood, and the growing merger between intelligence, capital, and technology — with a sharp focus on what all of this means for India's sovereignty and strategic future. This episode isn't about headlines. It's about the architecture beneath them. ⸻ ⏱️ Chapters 00:00 – 01:10 • Opening Hook: Power Beyond Governments 01:10 – 04:50 • Why Peace Is Often an Illusion in Geopolitics 04:50 – 09:10 • Sub-Nuclear Conflict & Why Wars Don't Need Victory 09:10 – 13:30 • Intelligence, Narratives & How Wars Are Justified 13:30 – 17:30 • Wealth Is Power: Who Really Controls the World 17:30 – 21:45 • The Military-Industrial Cycle & Perpetual Conflict 21:45 – 26:10 • NGOs, Aid Agencies & Influence Without Guns 26:10 – 31:20 • Big Tech, Think Tanks & the Revolving Door of Power 31:20 – 36:40 • Hollywood, Media & Manufacturing Consent 36:40 – 42:30 • Europe, Russia & the Politics of Fear 42:30 – 48:00 • Ukraine, Proxies & the Business of War 48:00 – 53:20 • Pandemics, Power & Too Many Coincidences 53:20 – 58:40 • Population Control, Capital & Global Elites 58:40 – 01:04:10 • What the “Deep State” Really Means 01:04:10 – 01:10:30 • How Nations Defend Themselves Today 01:10:30 – 01:22:18 • India's Choices in a World of Hidden Power ⸻

In episode 1990, Jack and Miles are joined by comedian, writer, journalist, and host of The Bitchuation Room, Francesca Fiorentini, to discuss... Markwayne Mullin Not Sure What A Regime Is Or What Change Is, RFK Jr With A BANGER Appearance On Katie Goebbels’ Podcast Between Two Swastikas, Dems Willing To Stay Out Of Power To Appease Donors and more! Markwayne Mullin Not Sure What A Regime Is Or What Change Is RFK Jr With A BANGER Appearance On Katie Goebbels’ Podcast: Between Two Swastikas Katie Miller to RFK JR.: "What brand of vitamins do you take?" Gavin Newsom comes out swinging against California billionaire tax Searchlight Memo to Interested Parties: Reform and Retrain ICE, Don’t Abolish It LISTEN: Knock Yourself Out (feat. Pharrell) by JadakissSee omnystudio.com/listener for privacy information.

What happens when war becomes a market and foreign policy turns into an odds board? We dive into the uneasy world of prediction platforms like Polymarket and Kalshi, where traders place bets on battlefield maps, covert raids, and even the exact words politicians will say. With researcher Nick Cleveland Stout from the Quincy Institute, we unpack how a briefly altered Ukraine map preceded a major payout, why a $400,000 win hit just hours before a surprise operation in Venezuela, and how these signals can tip off adversaries long before headlines catch up. Together we explore the ethics and incentives behind “the news of tomorrow today.” If market rules hinge on a single source, a map tweak or an official statement can decide millions—inviting manipulation rather than insight. We look closely at the regulatory blind spot: the CFTC treats these venues as prediction markets, leaving no insider trading framework even when life-and-death events are on the line. That vacuum tempts those with privileged access to profit, while retail bettors absorb the risk and confusion. The conversation follows the money. Defense contractors tout hardware after high-profile raids, budgets swell, and the arms industry wins. Oil players eye Venezuela's reserves and refineries, with some majors ready to expand and others demanding ironclad guarantees after prior expropriations. We examine how talk of reimbursements, control over refining, and contested asset sales like Sitgo feed a broader strategy to exert power without boots on the ground—and how markets amplify or distort that story. If prediction markets can surface real signals, they can also nudge reality. We outline concrete guardrails: diversified resolution sources, audit trails, institutional no-trade policies, event-type limits for active conflicts, and anomaly flags when flows cluster around sensitive moments. Then we ask the core question: should anyone profit from outcomes they can influence? Listen and decide with us, and if this conversation sharpened your thinking, follow the show, share it with a friend, and leave a review so others can find it.

The DGS Think Tank with Daniela Velasquez & Kurt Bahr- h4 full 1104 Tue, 13 Jan 2026 22:35:33 +0000 vylsxBb7kV0SBTVpWwuuc67iypIqdbOf comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government The DGS Think Tank with Daniela Velasquez & Kurt Bahr- h4 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False https://player.amperwavepodcasting.

Cody Alexander of MatchQuarters joins the Nation to have an "Defensive Think Tank" conversation full 954 Mon, 12 Jan 2026 23:13:18 +0000 9Ik5A3YU4gGTIxFkJCSlouWz0zpvSRi2 nfl,dallas cowboys,sports GBag Nation nfl,dallas cowboys,sports Cody Alexander of MatchQuarters joins the Nation to have an "Defensive Think Tank" conversation The G-Bag Nation - Weekdays 10am-3pm 2024 © 2021 Audacy, Inc. Sports False

Chad and Jordan discuss the early offseason, trades, and how to implement a winning strategy.Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

Australian born, American – based, distinguished foreign policy commentator, Danielle Pletka, frames the dramatic U.S. seizure and arrest of Nicolas Maduro, not simply as an enforcement of criminal indictments, but as a pivotal moment in long-running political tensions.

The DGS Think Tank with Dennis Hancock & Donna Baringer- h4 full 1139 Tue, 06 Jan 2026 22:32:02 +0000 R7UsGCrN3OslYHbllEgjkHYn5mlgm3WR comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government The DGS Think Tank with Dennis Hancock & Donna Baringer- h4 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False https://player.amperwavepodcastin

Chad and Jordan discuss the final week of the season and look to the future with some rules to consider when trading in the offseason.Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

Welcome to Season 11 of the Rethink Community Podcast: The Best Of! For the past five years, the Rethink Community Podcast has been a space to challenge how we understand and respond to poverty. We've shared stories that move beyond theory and spark those "aha moments" that can change perspectives, relationships, and actions. In this special season, we're bringing you the best of our past episodes—powerful stories, inspiring conversations, and thought-provoking insights that have resonated most with our listeners. You'll hear from individuals with lived experience in poverty, addiction, or incarceration; people who have built bridges across race and class; and leaders whose understanding of poverty has shifted through real-world experience. Whether you're new to the podcast or a longtime listener, these episodes capture the heart of what Rethink Community is all about: opening our eyes, expanding our empathy, and sparking new ideas for a more just and connected world. So, get ready to revisit some of our most compelling conversations and join us in Season 11—the best of Rethink Community. Original Air Date: Season 7, Spring 2023 In 2010, a group of people from Greater Dayton Ohio, teamed up with Think Tank, Inc. to share their personal experiences with poverty. Their stories became the foundation for the Cost of Poverty Experience — a simulation that gives people a glimpse into the lived realities of poverty. Since then, COPE has helped thousands across the country see poverty from a human perspective. Now, some of those original storytellers are back to share where life has taken them, the relationships and resources that shaped their journeys, and their powerful reflections on how we talk about poverty in America today.  This compilation includes clips from the following guests: Carlos Guajardo Krisitin Hicks Melissa Massey Ken Moss  

In this episode, Dan Hugger speaks with Kris Mauren, co-founder and president of the Acton Institute, about all things Acton. What was the original, animating idea behind the founding of the Acton Institute? Why a think tank? What makes Grand Rapids so grand? What are the greatest challenges Acton faces in fulfilling its mission? What […]

Chad and Jordan react to a tough week 16 plus dynasty trades heading into week 17 championships!Plus hours of premium content this month!  You can get all the DTT Patreon content for $10 a month at patreon.com/DynastyThinkTank.Follow Chad on Twitter: @chadparsonsNFLFollow Jordan on Twitter: @mcnamaradynasty 

Chad and Jordan discuss how to handle the Patrick Mahomes ACL tear and how to not make a bad situation way worse.Plus lots of trades and strategy.  

The DGS Think Tank with Ian Mackey & Steve Ehlmann- h4 full 931 Tue, 16 Dec 2025 22:36:21 +0000 fLLWzYpSI6lL7XcJ2zIISroezwAIbMNH comedy,religion & spirituality,society & culture,news,government The Dave Glover Show comedy,religion & spirituality,society & culture,news,government The DGS Think Tank with Ian Mackey & Steve Ehlmann- h4 The Dave Glover Show has been driving St. Louis home for over 20 years. Unafraid to discuss virtually any topic, you'll hear Dave and crew's unique perspective on current events, news and politics, and anything and everything in between. © 2025 Audacy, Inc. Comedy Religion & Spirituality Society & Culture News Government False https://player.amperwavepodcasting.com

In Episode 132: Hollow Earth and What Lives Within, we “dive in” to hollow Earth with another edition of the Think Tank! Is a hollow Earth really possible? If so, why is it there? Who lives inside of it? What is it being used for? These thought-provoking questions and many more will be covered as Justen Faull, Wes Faull, Chad Riley, and Jim Wilhelmsen join The Confessionals to discuss the mysterious hollow Earth. Please pray for Tony's wife, Lindsay, as she battles breast cancer. Your prayers make a difference! If you're able, consider helping the Merkel family with medical expenses by donating to Lindsay's GoFundMe: https://gofund.me/b8f76890 Become a member for ad-free listening, extra shows, and exclusive access to our social media app: theconfessionalspodcast.com/join The Confessionals Social Network App: Apple Store: https://apple.co/3UxhPrh Google Play: https://bit.ly/43mk8kZ Tony's Recommended Reads: slingshotlibrary.com If you want to learn about Jesus and what it means to be saved: Click Here Bigfoot: The Journey To Belief: Stream Here The Meadow Project: Stream Here Merkel Media Apparel: merkmerch.com My New YouTube Channel Merkel IRL: @merkelIRL My First Sermon: Unseen Battles SPONSORS SIMPLISAFE TODAY: simplisafe.com/confessionals GHOSTBED: GhostBed.com/tony CONNECT WITH US Website: www.theconfessionalspodcast.com Email: contact@theconfessionalspodcast.com MAILING ADDRESS: Merkel Media 257 N. Calderwood St., #301 Alcoa, TN 37701 SOCIAL MEDIA Subscribe to our YouTube: https://bit.ly/2TlREaI Reddit: https://www.reddit.com/r/theconfessionals/ Discord: https://discord.gg/KDn4D2uw7h Show Instagram: theconfessionalspodcast Tony's Instagram: tonymerkelofficial Facebook: www.facebook.com/TheConfessionalsPodcas Twitter: @TConfessionals Tony's Twitter: @tony_merkel Produced by: @jack_theproducer